Crossmark

Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants

Crossref DOI link: https://doi.org/10.1016/j.vaccine.2017.07.008

Published Print: 2017-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Prymula, Roman

Szenborn, Leszek

Silfverdal, Sven-Arne

Wysocki, Jacek

Albrecht, Piotr

Traskine, Magali

Gardev, Asparuh

Song, Yue

Borys, Dorota
License Information

Text and Data Mining valid from 2017-08-01

Version of Record valid from 2017-07-13
More Information

This article is maintained by: Elsevier

Article Title: Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants

Journal Title: Vaccine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vaccine.2017.07.008

Content Type: article

Copyright: © 2017 GlaxoSmithKline Biologicals. Published by Elsevier Ltd.

Document is current

Any future updates will be listed below